Shanghai Pharmaceuticals Holding has a total of 1154 patents globally, out of which 732 have been granted. Of these 1154 patents, more than 63% patents are active. China is where Shanghai Pharmaceuticals Holding has filed the maximum number of patents, followed by United States of America and Europe, it has generated an annual revenue of $3.73 billion in the year 2020. Parallelly, China seems to be the main focused R&D center and is also the origin country of Shanghai Pharmaceuticals Holding.
Shanghai Pharmaceuticals Holding was founded in the year 1994. Company is doing business in developing and distributing pharmaceutical products. As of January 2022, Shanghai Pharmaceuticals Holding has a market cap of $5.9 Billion.
Do read about some of the most popular patents of Shanghai Pharmaceuticals Holding which have been covered by us in this article and also you can find Shanghai Pharmaceuticals Holding’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Shanghai Pharmaceuticals Holding’s patent portfolio.
How many patents does CEO of Shanghai Pharmaceuticals Holding have?
The CEO, Da Wei Liu has 0 patents.
How many patents does Shanghai Pharmaceuticals Holding have?
Shanghai Pharmaceuticals Holding has a total of 1154 patents globally. These patents belong to 945 unique patent families. Out of 1154 patents, 733 patents are active.
How many Shanghai Pharmaceuticals Holding patents are Alive/Dead?
Worldwide Patents
Patent Families
How Many Patents did Shanghai Pharmaceuticals Holding File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Shanghai Pharmaceuticals Holding Applications Filed | Shanghai Pharmaceuticals Holding Patents Granted |
| 2011 | 26 | 37 |
| 2012 | 65 | 25 |
| 2013 | 77 | 35 |
| 2014 | 46 | 41 |
| 2015 | 64 | 47 |
| 2016 | 81 | 46 |
| 2017 | 91 | 40 |
| 2018 | 105 | 44 |
| 2019 | 116 | 48 |
| 2020 | 111 | 89 |
| 2021 | 42 | 103 |
| 2022 | – | 2 |
How Many Patents did Shanghai Pharmaceuticals Holding File in Different Countries?
Countries in which Shanghai Pharmaceuticals Holding Filed Patents
| Country | Patents |
| China | 948 |
| United States Of America | 33 |
| Europe | 20 |
| Japan | 19 |
| Canada | 9 |
| Germany | 7 |
| Australia | 6 |
| Korea (South) | 5 |
| Hong Kong (S.A.R.) | 5 |
| United Kingdom | 4 |
| Taiwan | 4 |
| Brazil | 4 |
| Israel | 4 |
| Spain | 3 |
| Denmark | 3 |
| Portugal | 2 |
| India | 2 |
| Russia | 2 |
| Italy | 1 |
| Hungary | 1 |
| Poland | 1 |
| Austria | 1 |
| South Africa | 1 |
| Philippines | 1 |
| Slovenia | 1 |
| Mexico | 1 |
Where are Research Centers of Shanghai Pharmaceuticals Holding Patents Located?
10 Best Shanghai Pharmaceuticals Holding Patents
WO2014086284A1 is the most popular patent in the Shanghai Pharmaceuticals Holding portfolio. It has received 53 citations so far from companies like Kala Pharmaceuticals, Shilpa Medicare and Array Biopharma.
Below is the list of 10 most cited patents of Shanghai Pharmaceuticals Holding:
| Publication Number | Citation Count |
| WO2014086284A1 | 53 |
| US6187314B1 | 35 |
| CN103304572A | 32 |
| CN102875537A | 27 |
| CN101427764A | 22 |
| CN1977841A | 22 |
| WO2013170774A1 | 21 |
| CN1520797A | 16 |
| WO2015018356A1 | 16 |
| CN103654981A | 15 |
What Percentage of Shanghai Pharmaceuticals Holding US Patent Applications were Granted?
Shanghai Pharmaceuticals Holding (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 11 have been granted leading to a grant rate of 91.67%.
Below are the key stats of Shanghai Pharmaceuticals Holding patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Shanghai Pharmaceuticals Holding?
| Law Firm | Total Application | Success Rate |
| Birch Stewart Kolasch & Birch Llp | 5 | 100.00% |
| Pilloff Passino & Cosenza Llp | 5 | 100.00% |
| Houston Beshining Law Office Pllc | 1 | 100.00% |
| Nixon & Vanderhye Pc | 1 | 0.00% |
| Oliff Plc | 1 | 100.00% |
Innovative medications, chemical drugs, traditional Chinese medicines, and rare disease drugs are among Shanghai Pharmaceuticals Holding’s offerings. The cardiovascular system, digestive tract, and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system, and respiratory system are all areas where the company’s products are used. Medical logistics and warehousing services are also provided by the company. The company sells its products both in the domestic markets and internationally.
EXCLUSIVE INSIGHTS COMING SOON!
What are Shanghai Pharmaceuticals Holding key innovation segments?
What Technologies are Covered by Shanghai Pharmaceuticals Holding?
The chart below distributes patents filed by Shanghai Pharmaceuticals Holding in different countries on the basis of the technology protected in patents. It also represents the markets where Shanghai Pharmaceuticals Holding thinks it’s important to protect particular technology inventions.
R&D Focus: How Shanghai Pharmaceuticals Holding search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Shanghai Pharmaceuticals Holding?